<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-five women with prosthetic heart valves (<z:chebi fb="0" ids="53390">PHV</z:chebi>) became pregnant 28 times </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-six of the pregnancies occurred while the patients were receiving oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> and these were continued throughout in 25 pregnancies </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4653">Dipyridamole</z:chebi> or <z:chebi fb="0" ids="4653">dipyridamole</z:chebi> and acetylsalicyclic acid were used in 22 pregnancies </plain></SENT>
<SENT sid="3" pm="."><plain>Eighteen infants were delivered, one with a congenital corneal leukoma; none had hemorrhagic complications; their psychomotor development was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Nine women aborted 10 times, including patients with two <z:chebi fb="0" ids="53390">PHV</z:chebi>, pelvic trauma and self-induced abortion </plain></SENT>
<SENT sid="5" pm="."><plain>We could not detect excess anticoagulation in eight of the nine who had spontaneous losses; excess anticoagulation occurred five weeks before an abortion </plain></SENT>
<SENT sid="6" pm="."><plain>There were no maternal <z:hpo ids='HP_0011420'>deaths</z:hpo> despite numerous complications; in two women, <z:e sem="disease" ids="C0262935" disease_type="Disease or Syndrome" abbrv="">brain embolism</z:e> was related to short interruptions of anticoagulation </plain></SENT>
<SENT sid="7" pm="."><plain>The details of management are mentioned </plain></SENT>
<SENT sid="8" pm="."><plain>We lack enough evidence to suggest routine sterilization, routine interruption of <z:chebi fb="2" ids="28794">coumarin</z:chebi> therapy during pregnancy or routine interruption of pregnancy in women with certain types and models of <z:chebi fb="0" ids="53390">PHV</z:chebi>; however, pregnancy under such conditions, plus antithrombotic therapy, carries a high risk for the product and a potential teratogenic effect </plain></SENT>
<SENT sid="9" pm="."><plain>Women with one or two <z:chebi fb="0" ids="53390">PHV</z:chebi> can have children if their management is closely supervised and if extreme care is taken with the use of oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
</text></document>